216574-57-1

Basic information

• Product Name: 2-Furancarboxylicacid,3-amino-5-(1,1-dimethylethyl)-,methylester(9CI)
• Synonyms: 2-Furancarboxylicacid,3-amino-5-(1,1-dimethylethyl)-,methylester(9CI)
• CAS NO: 216574-57-1
• Molecular Formula: C₁₀H₁₅NO₃
• Molecular Weight: 197.23
• Product Categories: AMINOACID
• Mol File: 216574-57-1.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Furancarboxylicacid,3-amino-5-(1,1-dimethylethyl)-,methylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Furancarboxylicacid,3-amino-5-(1,1-dimethylethyl)-,methylester(9CI)(216574-57-1)
• EPA Substance Registry System: 2-Furancarboxylicacid,3-amino-5-(1,1-dimethylethyl)-,methylester(9CI)(216574-57-1)

Safety Data

• Hazardous Substances Data: 216574-57-1(Hazardous Substances Data)

Upstream product

• 96-35-5 glycolic acid methyl ester 
• 216574-58-2 3-chloro-4,4-dimethylpent-2-enenitrile 
• 216574-56-0 methyl 3-azido-5-tert-butylfuran-2-carboxylate 
• 29586-83-2 (2Z)-3-chloro-4,4-dimethylpent-2-enenitrile 
• 59907-23-2 methyl 5-(tert-butyl)furan-2-carboxylate 

Downstream Products

• 59907-23-2 methyl 5-(tert-butyl)furan-2-carboxylate 

Relevant articles and documents

RAF KINASE INHIBITORS

Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.

Inhibition of p38 kinase activity by aryl ureas

This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.